Biontech plans to examine mRNA technology for malaria vaccines

Pharmaceutical company Biontech plans to create a vaccine for malaria based on the same mRNA technology as the firm's vaccine for covid-19, which the German company developed in collaboration with Pfizer.

German firm Biontech, which in collaboration with Pfizer has developed one of the most widely-used coronavirus vaccines, now plans to create a vaccine against malaria.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
Must contain at least 6 characters
Must contain at least 2 characters
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Front page now

Further reading